Antibody developed by Dr. Weissman and his colleagues shows promise in a small clinical trial as a safe cancer therapy

Previous
Previous

SDRC researchers use zinc to target insulin producing cells

Next
Next

The ISPAD Clinical Practice consensus Guidelines 2018 are now available online